BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38804898)

  • 41. NITROSAMINE CONTAMINATION WITHIN CARDIAC MULTIMEDICATION - SARTANS (VALSARTAN), CALCIUM CHANNEL BLOCKERS (AMLODIPINE AND NIFEDIPINE), AND ANTIARRHYTHMICS (PROPAFENONE) AS A SIGNIFICANT FACTOR IN THE DEVELOPMENT AND PROGRESSION OF MULTIPLE KERATINOCYTIC CANCERS: ADVANCEMENT ROTATION FLAP FOR KERATOACANTHOMA OF THE UPPER LIP AND UNDERMINING SURGERY FOR BCC OF THE SHOULDER AS AN OPTIMAL DERMATOSURGICAL APPROACH.
    Tchernev G
    Georgian Med News; 2023 Sep; (342):152-155. PubMed ID: 37991972
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantitative structure carcinogenicity relationship for detecting structural alerts in nitroso-compounds.
    Helguera AM; González MP; D S Cordeiro MN; Pérez MA
    Toxicol Appl Pharmacol; 2007 Jun; 221(2):189-202. PubMed ID: 17477948
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genotoxicity assessment of eight nitrosamines using 2D and 3D HepaRG cell models.
    Seo JE; Yu JZ; Xu H; Li X; Atrakchi AH; McGovern TJ; Bruno KLD; Mei N; Heflich RH; Guo X
    Arch Toxicol; 2023 Oct; 97(10):2785-2798. PubMed ID: 37486449
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genotoxicity assessments of N-nitrosoethylisopropylamine (NEIPA) and N-nitrosodiisopropylamine (NDIPA) in the C57BL/6J mouse.
    Ye Q; Geng X; Jiang H; Qin C; Wu H; Wang S; Wen H
    Mutat Res Genet Toxicol Environ Mutagen; 2024; 896():503763. PubMed ID: 38821676
    [TBL] [Abstract][Full Text] [Related]  

  • 45. (NDMA) METFORMIN AND (NTTP) SITAGLIPTIN INDUCED CUTANEOUS MELANOMAS: LINKS TO NITROSOGENESIS, NITROSO-PHOTOCARCINOGENESIS, ONCOPHARMACOGENESIS AND THE METABOLIC REPROGRAMMING.
    Tchernev G; Broshtilova V
    Georgian Med News; 2024 Mar; (348):132-143. PubMed ID: 38807407
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ames test study designs for nitrosamine mutagenicity testing: qualitative and quantitative analysis of key assay parameters.
    Thomas DN; Wills JW; Tracey H; Baldwin SJ; Burman M; Williams AN; Harte DSG; Buckley RA; Lynch AM
    Mutagenesis; 2024 Mar; 39(2):78-95. PubMed ID: 38112628
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Specific and total N-nitrosamines formation potentials of nitrogenous micropollutants during chloramination.
    Piazzoli A; Breider F; Aquillon CG; Antonelli M; von Gunten U
    Water Res; 2018 May; 135():311-321. PubMed ID: 29524858
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A deep dive into historical Ames study data for N-nitrosamine compounds.
    Tennant RE; Ponting DJ; Thresher A
    Regul Toxicol Pharmacol; 2023 Sep; 143():105460. PubMed ID: 37495012
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantitative structure-carcinogenicity relationship for detecting structural alerts in nitroso compounds: species, rat; sex, female; route of administration, gavage.
    Morales Helguera A; Pérez González M; Dias Soeiro Cordeiro MN; Cabrera Pérez MA
    Chem Res Toxicol; 2008 Mar; 21(3):633-42. PubMed ID: 18293904
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cytochrome P450 2A-catalyzed metabolic activation of structurally similar carcinogenic nitrosamines: N'-nitrosonornicotine enantiomers, N-nitrosopiperidine, and N-nitrosopyrrolidine.
    Wong HL; Murphy SE; Hecht SS
    Chem Res Toxicol; 2005 Jan; 18(1):61-9. PubMed ID: 15651850
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [SELECTIVE INDUCTION OF CARCINOMA OF THE PARANASAL SINUSES IN RATS WITH N,N'-DI-NITROSOPIPERAZINE, NITROSOPIPERIDINE, NITROSOMORPHOLINE, METHYLALLYL-, DIMETHYL- AND METHYLVINYL NITROSAMINE].
    DRUCKREY H; IVANKOVIC S; MENNEL HD; PREUSSMANN R
    Z Krebsforsch; 1964 May; 66():138-50. PubMed ID: 14217052
    [No Abstract]   [Full Text] [Related]  

  • 52. Use of less-than-lifetime (LTL) durational limits for nitrosamines: Case study of N-Nitrosodiethylamine (NDEA).
    Bercu JP; Masuda-Herrera M; Johnson G; Czich A; Glowienke S; Kenyon M; Thomas R; Ponting DJ; White A; Cross K; Waechter F; Rodrigues MAC
    Regul Toxicol Pharmacol; 2021 Jul; 123():104926. PubMed ID: 33862169
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Occurrence of nitroso compounds in fungi-contaminated foods: a review.
    Li MH; Ji C; Cheng SJ
    Nutr Cancer; 1986; 8(1):63-9. PubMed ID: 3520493
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fluoro-substituted N-nitrosamines. 7. Non-genotoxic N-nitroso-bis(2,2,2-trifluoroethyl)amine and N-nitroso-bis(2,2,3,3,4,4,4-heptafluorobutyl)amine: binding to cytochrome P-450, acidity of alpha-protons and pharmacokinetic investigations.
    Janzowski C; Gottfried J; Preussmann R; Eisenbrand G
    Carcinogenesis; 1985 Jan; 6(1):79-84. PubMed ID: 2981643
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis and Trace-Level Quantification of Mutagenic and Cohort-of-Concern Ciprofloxacin Nitroso Drug Substance-Related Impurities (NDSRIs) and Other Nitroso Impurities Using UPLC-ESI-MS/MS-Method Optimization Using I-Optimal Mixture Design.
    Nakka S; Katari NK; Muchakayala SK; Jonnalagadda SB; Manabolu Surya SB
    ACS Omega; 2024 Feb; 9(8):8773-8788. PubMed ID: 38434810
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nitrosamine carcinogenicity: a quantitative Hansch-Taft structure-activity relationship.
    Wishnok JS; Archer MC; Edelman AS; Rand WM
    Chem Biol Interact; 1978 Jan; 20(1):43-54. PubMed ID: 630644
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Approaches to cancer prevention based on an understanding of N-nitrosamine carcinogenesis.
    Hecht SS
    Proc Soc Exp Biol Med; 1997 Nov; 216(2):181-91. PubMed ID: 9349687
    [TBL] [Abstract][Full Text] [Related]  

  • 58. NITROSAMINES IN COMMONLY PRESCRIBED ANTIHYPERTENSIVES AND THE (UN)CONTROLLED DRUG-INDUCED SKIN CANCER: SIMULTANEOUS DEVELOPMENT OF CUTANEOUS MELANOMA AND MULTIPLE BCC AFTER CONCOMITANT ADMINISTRATION OF BISOPROLOL AND FUROSEMIDE.
    Tchernev G
    Georgian Med News; 2023 Sep; (342):149-151. PubMed ID: 37991971
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Cautionary Tale: Quantitative LC-HRMS Analytical Procedures for the Analysis of N-Nitrosodimethylamine in Metformin.
    Yang J; Marzan TA; Ye W; Sommers CD; Rodriguez JD; Keire DA
    AAPS J; 2020 Jul; 22(4):89. PubMed ID: 32613429
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fluoro-substituted N-nitrosamines. 8. N-Nitrosodibutylamine and omega-fluorinated analogues: in vivo metabolism in relation to the induction of urinary bladder cancer in the rat.
    Gottfried-Anacker J; Preussmann R; Eisenbrand G; Janzowski C
    Carcinogenesis; 1985 Nov; 6(11):1559-64. PubMed ID: 4053275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.